1. Home
  2. MNY vs SCLX Comparison

MNY vs SCLX Comparison

Compare MNY & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MoneyHero Limited

MNY

MoneyHero Limited

N/A

Current Price

$1.44

Market Cap

54.1M

Sector

N/A

ML Signal

N/A

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$8.54

Market Cap

59.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MNY
SCLX
Founded
2014
2011
Country
Singapore
United States
Employees
N/A
30
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.1M
59.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MNY
SCLX
Price
$1.44
$8.54
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$4.00
N/A
AVG Volume (30 Days)
45.0K
33.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.58
$749.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.18
52 Week High
$2.40
$34.27

Technical Indicators

Market Signals
Indicator
MNY
SCLX
Relative Strength Index (RSI) 56.87 46.70
Support Level $1.31 $7.73
Resistance Level $1.52 $9.00
Average True Range (ATR) 0.06 0.56
MACD 0.00 0.18
Stochastic Oscillator 50.00 67.42

Price Performance

Historical Comparison
MNY
SCLX

About MNY MoneyHero Limited

MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: